Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Patients With Sarcomatoid Renal Cell Carcinoma – Re-Defining the First-Line of Treatment: A Meta-Analysis of Randomised Clinical Trials With Immune Checkpoint InhibitorsEur. J. Cancer 2020 Jul 23;136(xx)195-203, R Iacovelli, C Ciccarese, E Bria, S Bracarda, C Porta, G Procopio, G Tortora
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.